Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?

Alistair B.A. Boxall(Science City York (United Kingdom)), Glen Van Der Kraak(University of Guelph), Vance L. Trudeau(University of Ottawa), D. G. Joakim Larsson(University of Gothenburg), Jason Snape(AstraZeneca (United Kingdom)), John P. Giesy(University of Saskatchewan), Frank Mastrocco(Pfizer (United States)), Mark E. McMaster(Environment and Climate Change Canada), Lars Hällström(University of Alberta), Bryan W. Brooks(Baylor University), Jürg Oliver Straub(Roche (Switzerland)), Kim Ostapyk(Health Canada), Paul C. DeLeo(Deutsches Historisches Institut Washington), Jon F. Ericson(Pfizer (United States)), Silke Hickmann(German Environment Agency), Kyungho Choi(Seoul National University), Daniel J. Caldwell(Johnson & Johnson (United States)), Gerald R. Tetreault(University of Waterloo), Edward Topp(Western University), François Gagné(Environment and Climate Change Canada), Elizabeth Innes(Health Canada), Gerald T. Ankley(Environmental Protection Agency), Todd Gouin(Unilever (United Kingdom)), Scott E. Belanger(Procter & Gamble (United States)), Roger D. Meyerhoff(Eli Lilly (United States)), Maja Karlsson(University of York), Murray A. Rudd(University of York), Paul K. Sibley(University of Guelph), Karen Beazley(Dalhousie University), Mark R. Servos(University of Waterloo), Pedro Carriquiriborde(Universidad Nacional de La Plata), Joanne L. Parrott(Environment and Climate Change Canada), Richard Murray‐Smith(AstraZeneca (United Kingdom)), Jane Staveley(Exponent (United States)), Jason P. Berninger‌(Baylor University), Nora D. Szabo(University of Ottawa), Anja Coors(ECT Oekotoxikologie (Germany)), James M. Lazorchak(Environmental Protection Agency), Scott D. Dyer(Procter & Gamble (United States)), Roberta Moore(Health Canada), Alison McLaughlin(Health Canada), Tim Verslycke(Gradient (United States))
Environmental Health Perspectives
May 30, 2012
Cited by 1,337


Related Papers